Chapter 811 One pill costs 25.82 million? 120,000 vehicles sold on the first day, generating 104.7 billion in revenue!



Chapter 811 One pill costs 25.82 million? 12,000 vehicles sold on the first day, generating 10.47 billion in revenue!

When Benson saw Chen Yansen enter the conference room, he immediately stood up, and his assistant quickly stepped forward to help him.

Chen Yansen's gaze swept over Bansen, sizing him up from head to toe.

The person was over ninety years old. Although his face was full of wrinkles and age spots, and his hair was silver, he was in good spirits and had a rosy complexion.

As the owner of both the New Orleans Saints and the New Orleans Pelicans, and also owning multiple car dealerships, banks, and real estate projects, his publicly estimated net worth is over $4 billion, but his actual wealth has long exceeded $15 billion.

The wealth accumulated over decades is already an astronomical figure.

That's why his daughter and grandson were willing to take him to court over the distribution of his estate.

"Mr. Chen, I..."

Before Benson could finish speaking, Chen Yansen placed a bottle of medicine on the table.

“Mr. Benson, I know why you’ve come, but BrainShield has not yet undergone human clinical trials. Giving the drug to you directly is not in accordance with the law.”

Chen Yansen spoke slowly and deliberately.

After submitting the application materials for review, a new drug must first complete pharmacological studies to explore core data such as the drug's mechanism of action, efficacy, and pharmacokinetics.

Toxicological studies will also be conducted, including multiple tests such as acute toxicity, long-term toxicity, carcinogenicity, mutagenicity, and reproductive toxicity.

It's simply impossible for a drug to be developed one second and put on the market the next!

If a large-scale medical accident occurs, no one can afford the consequences.

Clinical trials alone are divided into three phases:

The first phase typically involves recruiting 20 to 100 healthy volunteers over a period of several months. The core objective is to assess the safety, tolerability, and metabolic patterns of the drug, determine the safe dosage range, and screen for serious toxic reactions.

In the second phase, the number of participants was expanded to 100 to 300 patients with the target disease, with the duration ranging from several months to two years. While continuously monitoring safety, the efficacy of the drug was systematically verified for the first time. The dosage was optimized through grouped trials, and a clearly effective treatment plan was screened out.

In the third phase, the number of participants will be expanded to 1,000 to 3,000 or even more patients, with a duration of 1 to 4 years. This phase will be conducted in a broader and more complex patient population to compare the efficacy and safety of the new drug with existing standard therapies, and to comprehensively collect long-term adverse reaction data to provide core support for the drug's market launch.

Only when the data in the third phase meets the requirements can the new drug application be submitted.

The standard review period is 10 months, but the priority review period for urgently needed drugs such as anti-cancer drugs and drugs for rare diseases can be shortened to 6 months.

In other words, even if Benson goes through the fastest process, he will have to wait at least two years.

"Mr. Chen, I just want to know if it actually works?"

Benson leaned forward, staring intently at Chen Yansen's expression, trying to use his ninety years of life experience to judge whether the other party was telling the truth.

"It works! One cycle consists of 12 pills, and two cycles can reverse neuronal blockage and inflammation."

Chen Yansen responded with certainty.

“Mr. Chen, I can’t wait two years.”

Benson pleaded with a wry smile.

Let alone two years, he might not even be able to survive one year.

What's the use of having a lot of money if someone's stupid?

“I would never dare to sell non-compliant drugs.”

Chen Yansen shook his head.

Benson immediately understood that the other party was asking him to offer his own bargaining chips.

He pondered for a moment, then said seriously, "Mr. Chen, I own a small medical laboratory. You can sell NeuroGuard to me under the guise of a research collaboration. Name your price."

The subtext couldn't be clearer: he would help Orange Medical avoid legal risks and was willing to pay exorbitant drug prices.

Chen Yansen smiled but remained silent.

He didn't need Benson's paltry sums at all, and he had no interest in the team, bank, or real estate projects Benson owned.

If it's a technological asset with potential, it might be something that could entice him.

Seeing Chen Yansen's unmoved expression, Benson sighed slightly, then quickly realized what was going on.

Given Chen Yansen's status and wealth, ordinary prices simply cannot sway him.

"1 million US dollars. If it works, I will add another 20 million US dollars in six months."

Benson said through gritted teeth.

"I will not do anything illegal."

Chen Yansen leaned back and refused again.

"100 million US dollars!"

Upon seeing this, Benson immediately increased the price fivefold.

That's more like it!

Chen Yansen nodded slightly and raised his hand to signal, and Meng Yun then handed over the drug research and development cooperation agreement that had already been prepared.

Rules are rules, but people are flexible; there are always ways to avoid risks.

Benson looked at the agreement, unsure of what to say.

He spent 100 million US dollars on a bottle of 24 pills!

On average, one pill costs US$4.166 million, equivalent to RMB25.82 million, which is tens of thousands of times more expensive than gold!

As for the claim that he would make up the difference in six months, he dared not mention it again.

From Chen Yansen's eyes, he clearly read the unspoken meaning: without utmost sincerity, don't even think about getting NeuroGuard.

This was his life-saving medicine, and there was absolutely no room for negotiation.

Although Alzheimer's disease itself does not directly cause death, it can endanger life through long-term, progressive complications.

The core logic is that the disease damages brain function, causing patients to lose their basic living abilities, which in turn leads to fatal problems such as infection and organ failure.

Even a minor infection or a small fall may be insignificant to a healthy elderly person, but for an Alzheimer's patient, it could be the last straw that breaks the camel's back.

Benson is afraid of dying, which is why he was willing to ask for such an exorbitant price.

After signing the contract, Chen Yansen wanted to extend his hospitality, but seeing Benson's old and frail appearance, he ultimately gave up.

It would be quite unlucky if something happened at his company.

Benson gripped the medicine bottle tightly, eager to take a pill immediately, but reason told him that he must first test the drug's ingredients, then have someone test it on him, and only take it after confirming its safety.

He rested in Luzhou for one night and flew to the United States early the next morning.

Three days, two round trips, all for this bottle of life-saving medicine.

In fact, wealthy people like Benson are not uncommon.

To this day, the brain remains a medical no-go zone for humans.

Jonard's father also suffered from Alzheimer's disease, but he has long since passed away.

Otherwise, Verica would most likely have traveled a long way to beg for the medicine!

Meanwhile, Hebrew national treasure actor Haim, American legendary investor Richard, Bill Gates' father and DFS duty-free chain co-founder Chuck, and China's number one gigolo Li Chunping all suffer from Alzheimer's disease.

This shows that even with excellent medical conditions and abundant financial resources, it is impossible to completely prevent this disease.

Rumors that Benson had made a special trip to China to buy medicine after returning home quickly spread among the world's wealthy.

Upon learning of this, Bill Gates, at Microsoft headquarters in Washington state, immediately picked up his phone and called Chen Yansen.

He had the money to hire the best medical team and nurses for his father, maintaining his nutrition through nasogastric feeding, turning him over regularly to prevent bedsores, providing oral care to prevent aspiration pneumonia, and having dedicated caregivers to prevent falls, thus extending his father's lifespan.

But living like this is too undignified.

His current mindset is that he's trying anything, even if it's a long shot, just in case it works.

Within two days, the news had spread among Wall Street executives.

Both Benson and Bill Gates, two billionaires, have partnered with Baichen Pharmaceuticals, each investing $100 million in research and treatment for Alzheimer's disease.

The outside world was baffled, but Wall Street bigwigs knew perfectly well that this was just a roundabout strategy for purchasing drugs.

Is a drug that costs $100 million per bottle worth it?

For ordinary people, naturally no one would want to buy it.

But for the wealthy at the top of the business world, they can afford to pay 200 or 300 million US dollars as long as it can effectively prolong their lives.

Every year there are news reports of super-rich people donating to medical institutions and research laboratories. While there is certainly an element of kindness involved, many more do so because their family members or they themselves carry the genetic material for related lesions and are afraid that one day they will be struck by this disease.

However, this discussion faded away within a few days.

The reason is simple: the vast majority of people simply cannot afford the $100 million drug cost, not to mention that the actual efficacy of NeuroGuard is currently unknown.

On the other side.

After harvesting the rice from the T2 generation of Super Rice 2000, Chen Yansen then devoted himself to hybridization work on the F1 generation.

The purpose of this step is to make the characteristics of the target gene more prominent, thereby further improving the crop's yield, drought and insect resistance, as well as the content of γ-oryzanol and rice polyphenols.

As time passed day by day, June 8th arrived in the blink of an eye.

Outside the Luzhou International Conference Center, reporters gathered in droves, their flashes going off one after another.

Tesla, XPeng, Li Auto, BAIC, Great Wall Motors, JAC, and other automakers either had their chairmen attend in person or sent vice presidents to show their support.

After all, DeepBlue Technology is the "father" of all new energy vehicle brands, so who would dare to disrespect Senlian Group?

Even business tycoons like Lei Yijun, Zhou Hongyi, and Ding Lei made a special trip to Luzhou.

Meng Yuanzhi and the head of the Huian Transportation Association also entered the conference hall one after another.

Surprisingly, Chen Yansen did not appear until the press conference officially began, and Orange Auto CEO Wang Chao handled all the socializing.

Tens of millions of netizens from all over the world flooded into the live streaming rooms of Mimo, Kuaishou, and Douyin.

Everyone wants to see just how capable Orange Auto, which has been in preparation for nearly two years and is backed by Senlian Group, really is.

Wang Chao stood in the center of the stage at the press conference, marking his first public appearance in front of the media.

He started by discussing the exterior design of the Yaoguang E1, then went on to explain in detail the wheel styles, body materials, and the safety of the chassis, suspension, and braking system, disassembling and explaining each component one by one.

The standard version of the Yaoguang E1 uses the second-generation deep blue battery, equipped with an 80 kW 4890 battery pack, which is lighter and has a longer battery life.

The vehicle is equipped with a self-developed battery management and thermal management system that can closely monitor every level of the battery pack.

Data on the operating environment, from individual battery cells to the entire battery pack, including current, voltage, temperature, and humidity.

Each battery cell is equipped with a fuse at both ends. If the battery overheats or the current is too high, the fuse will immediately melt and disconnect the output, ensuring that the battery always operates within the optimal temperature range and improving cycle life and consistency.

Its real-world range exceeds 800 kilometers, far surpassing other models in its class.

In addition, the vehicle is equipped with the Mos Autodrive V1 system.

This is a unified camera neural network that can process data from eight cameras around the vehicle simultaneously, and has extremely strong environmental perception and object recognition capabilities.

It can identify objects within hundreds of meters in any direction and use the time difference between pairs of images to obtain depth information, helping vehicles accurately predict the trajectory of objects.

Combined with radar, 360-degree ultrasonic sensors, and driving data provided by Gaode Maps, it can realize core functions such as assisted steering, automatic lane changing, distance keeping, and automatic emergency braking, significantly reducing the intensity of driving operations.

In terms of power, the Yaoguang E1 adopts a dual-motor all-wheel drive system.

Each axle is equipped with a motor, enabling independent digital control of the torque of the front and rear wheels, improving the accuracy of traction control and enhancing the vehicle's grip and handling performance.

The two motors can leverage their respective characteristics to optimize the efficiency of the drive system under different operating conditions.

It accelerates from 0 to 100 km/h in just 2.9 seconds!

Meanwhile, the vehicle is also equipped with practical functions such as navigation, blind spot warning, and enhanced reversing assist. The cab features a 17-inch central control screen that integrates almost all physical button functions, making it easy to operate and giving it a strong sense of technology.

When Wang Chao announced the price, a gasp of amazement erupted from the audience at the press conference.

The standard version is priced at 699,000 yuan, and the top-of-the-line version is priced at 999,000 yuan!

The two differ in price by 300,000 yuan, and their driving range also differs by 800 kilometers.

In 2015, this price would have been considered a mid-range luxury car, making it extremely expensive for ordinary people, but just right for the wealthy.

It's worth noting that the first wave of Tesla Model S buyers mostly spent over a million yuan to purchase the car.

Therefore, the high price of the Yaoguang E1 did not deter potential buyers.

"Starting at 699,000? That's a really bold price!"

Reporters at the scene couldn't help but gasp, and the live stream chat was instantly flooded with comments.

Wang Chao had anticipated the discussions at the scene. He raised his hand to quell the noise and continued, "Some friends may think the price is too high, but I want to emphasize that every penny of the Yaoguang E1's price is spent on technology and security."

He pointed to the large screen behind him, on which a set of comparative data immediately appeared: "Among vehicles of the same class, our battery energy density is 35% higher than the industry average, with a cycle life of up to 1,500 cycles, and has passed multiple extreme safety tests such as needle penetration, extrusion, and high temperature."

Based on range performance, the standard battery pack can support at least 1.2 million kilometers of driving before its capacity decays to 80%, which can definitely meet the needs of ten to eight years of use.

In addition, Orange Auto has developed a dual-dimensional warranty policy for batteries, covering both time and mileage.

"More importantly, Senlian Group's supercharging network has been deployed simultaneously. Currently, there are 200 supercharging stations in operation nationwide, supporting fast charging to 70% in 20 minutes. In the next three years, this number will exceed 1,000."

As soon as Wang Chao finished speaking, a round of enthusiastic applause broke out in the room.

Within an hour of the press conference ending, Orange Auto's official website crashed due to a massive influx of orders.

By midnight that day, according to the data backend, the number of orders exceeded 12,000, with the top-of-the-line version accounting for more than 60%, and the estimated revenue reached 10.47 billion yuan.

Offline car dealerships also immediately sprang into action, making every effort to prepare for their official opening the following day.

Meanwhile, Benson, far across the ocean, finally found a suitable candidate for the drug trial.

The drug trial was conducted at his private island medical laboratory, which is equipped with world-class testing equipment and a medical team, and the drug response was recorded throughout the process.

Benson was willing to spend money, so he certainly didn't lack people to help him test the drugs.

(End of this chapter)

Continue read on readnovelmtl.com


Recommendation



Comments

Please login to comment

Support Us

Donate to disable ads.

Buy Me a Coffee at ko-fi.com
Chapter List